Andrew Futreal

Chair and Professor

The University of Texas MD Anderson Cancer Center
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (26)

S1. Heatmap of unsupervised hierarchical clustering of the top 1000 most variable genes.S2. Violin plots showing the expression levels of genes previously identified as differentially expressed genes between primary and recurrent tumors in Haltia et al., 2020.S3. Gene set enrichment analysis performed with GO terms and KEGG pathways showing that primarily immune-related and hormone-regulated gene sets expression are altered between primary and recurrent aGCTs.S4. Gene set enrichment analysis results showing that top enriched gene sets are significantly enriched in recurrent tumors in comparison with primary tumors.S5. Boxplot showing the fraction of each noncancerous cell type identified by CIBERSORTx (A) and xCell (B) in primary and recurrent tumor samples.S6. Heatmap showing the correlation between immune cells fractions.

Year:

2025

Immune cell analysis by BMI and sex. A. Immunohistochemistry (IHC) analysis of the MDA cohort stratified by BMI and sex. Line represents median +/- interquartile range; each dot represents a single tumor. B. IHC analysis of the Gide cohort stratified by BMI and sex. Line represents median +/- interquartile range; each dot represents a single tumor.

Year:

2025

Integrated gene set enrichment analysis of subgroups by body mass index BMI. This figure compares gene expression between overweight/obese (OW/OB) and normal (NL) BMI patients with metastatic melanoma across subgroups by sex, cohort, and tissue site. Supplementary Figure 2 presents a dotplot of genes differentially up- or downregulated in OW/OB patients versus NL BMI patients by subgroups. Red indicates upregulation in OW/OB verse NL.

Year:

2025

Integrated gene set enrichment analysis by body mass index (BMI) with correction for S phase. This figure presents a dotplot of genes differentially up- or downregulated in OW/OB patients versus NL BMI patients. Red indicates upregulation in OW/OB verse NL. The far left column is all patients, and then, an analysis controlling for sex, cohort, and tissue site is shown in the 3 columns to the right.

Year:

2025

Inverse Simpson alpha diversity scores of the fecal microbiome by BMI in patients with metastatic melanoma stratified by sex. Box plot represents the median bar with the box bounding the IQR and whiskers the most extreme points within 1.5 x IQR. The red dots represent OW/OB patients and the blue dots represent NL patients by BMI. This is a subgroup analysis of Figure 5C.

Year:

2025

Direct metabolite measurements from a subset of The Cancer Genome Atlas (TCGA) cohort. Comparison of additional tricarboxylic acid cycle metabolites measured by liquid chromatography/mass spectrometry between metastatic melanoma tumors from overweight/obese (OW/OB) patients by body mass index (BMI) verse normal (NL) BMI from The Cancer Genome Atlas (TCGA). Lines represent mean +/- SEM; each dot represents a single tumor.

Year:

2025

Immune cell analysis by BMI. A. Immunohistochemistry (IHC) analysis for CD8-, CD45RO-, FOXP3-, CD68-, GZMB-, PD-1-, LAG-3-, and CD3-positive cells in overweight/obese (OW/OB) verse normal (NL) tumors as defined by body mass index from the MD Anderson Cancer Center (MDA) cohort. Line represents median +/- interquartile range; each dot represents a single tumor. B. IHC analysis for PD-L1-, CD45RO-, FOXP3-, EOMES-, GZMB-, PD-1-, TBET-, and TBET:FOXP3-positive cells in OW/OB verse NL tumors as defined by body mass index from the Gide cohort. Line represents median +/- interquartile range; each dot represents a single tumor.

Year:

2025

Supplementary Table 1: Baseline characteristics for patients included in the integrated gene set enrichment analysis (Figure 2-3) by cohort; Supplementary Table 6: The most frequent somatic alterations (alts) in patients with regionally metastatic melanoma by body mass index from The Cancer Genome Atlas cohort; Supplemental Table 7: Integrated gene set enrichment analysis for pathways associated with fatty acid metabolism by body mass index; Supplemental Table 8: Gene expression of selected genes of interest involved in fatty acid metabolism.

Year:

2025

Beta-diversity analysis stratified by sex based on Bray-Curtis dissimilarity represents microbiome samples with metastatic melanoma in terms of the two top principal components (explaining around 17% of variance) obtained from the principal coordinate analysis. Red dots are from overweight/obese (OW/OB) BMI patients, and blue dots are from normal (NL) BMI patients. Shading inside the dots indicates the female gender. This is a subgroup analysis of Figure 5B.

Year:

2025

Adult type ovarian granulosa cell tumors (AGCT) are rare malignancies with the near universal c.C402G (p.Cys134Trp) somatic mutation in FOXL2 , a forkhead box family transcription factor important for ovarian function. Relapsed AGCT is incurable, but the mechanism of the unique FOXL2 mutation could confer therapeutic vulnerabilities. To identify FOXL2 C134W -dependent pharmacologic synergies, we created and characterized endogenous FOXL2 isogenic AGCT cells and an AGCT tumoroid biobank. A drug screen identified that glucocorticoids promote FOXL2 C134W -dependent AGCT growth. Epigenetic investigation revealed that the Cys134Trp mutation exposes latent DNA sequence–specific chromatin remodeling activity in FOXL2. FOXL2 C134W -dependent chromatin remodeling activity redirected glucocorticoid receptor chromatin occupancy to drive hyaluronan synthase 2 gene expression and increase extracellular hyaluronan secretion. Treatment of AGCT models with hyaluronidase reduced viability, and dexamethasone rescued this effect. Combinatorial drug–drug interaction experiments demonstrated that dexamethasone antagonizes the potency of paclitaxel, a chemotherapy agent frequently used in the treatment of AGCT. Thus, gain-of-function pioneering activity contributes to the oncogenic mechanism of FOXL2 C134W and creates a potentially targetable synergy with glucocorticoid signaling. Significance: Glucocorticoids promote granulosa cell tumor growth via epigenetic coregulation with the disease driver FOXL2 C134W , providing mechanistic insight into disease oncogenesis and uncovering a potential treatment strategy.

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Collaborators (104)

Matthew Campbell

Associate Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Xiuning Le

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

David Gerber

Professor of Internal Medicine (Hematology-Oncology) and Clinical Sciences

University of Texas Southwestern Medical Center

UNITED STATES
View details

Jianjun Zhang

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Michael Green

Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Dinler Antunes

Assistant Professor of Computational Biology

University of Houston

UNITED STATES
View details

Georgina V. Long

University of Sydney

AUSTRALIA
View details

Mark Davis

Howard Hughes Medical Institute

UNITED STATES
View details

Kanwal Raghav

Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Lauren Haydu

Assistant Professor of Biostatistics

Mayo Clinic

UNITED STATES
View details

Carrie Daniel

Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Michael A. Davies

-

UNITED STATES
View details

Elizabeth Christie

Peter MacCallum Cancer Institute

AUSTRALIA
View details

Hussein A. Abbas

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Jianjun Gao

Assistant Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

John Paul Shen

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Ajay Sheshadri

Assistant Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Lauren A. Byers

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Daniel M Halperin

Vice Chair for Clinical Affairs

Winship Cancer Institute of Emory University

UNITED STATES
View details

Shiro Takamatsu

Associate Lecturer

Kyoto University Hospital

JAPAN
View details

Sung-Eun Lee

-

SOUTH KOREA
View details

Chantale Bernatchez

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Ralph J. DeBerardinis

University of Texas Southwestern Medical Center

UNITED STATES
View details

Samuel Mok

Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Louis Pisters

Professor of Urology

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Melissa Taggart

Associate professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Jennifer L. McQuade

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Jun Li

Associate Professor

University of North Carolina at Chapel Hill

UNITED STATES
View details

Alexander M. Menzies

University of Sydney

AUSTRALIA
View details

Nora M. Navone

Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Theodore S. Nowicki

University of California

UNITED STATES
View details

Christopher J. Logothetis

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Anil Sood

Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Marina Konopleva

Professor

Albert Einstein College of Medicine

UNITED STATES
View details

Greg M. Delgoffe

-

UNITED STATES
View details

Jihoon Kim

Assistant Professor

Yale University

UNITED STATES
View details

Alejandra Flores Legarreta

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

John Kirkwood

Distinguished Service Professor of Medicine

University of Pittsburgh

UNITED STATES
View details

Clifford Stephan

Research Associate Professor

Texas A&M University Health Sciences Center

UNITED STATES
View details

David Gershenson

Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Maison Grefe

-

UNITED STATES
View details

Natalia Baran

Leading attending

University Hospital of Bern

SWITZERLAND
View details

Vashisht Yennu Nanda

Associate Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Junya Fujimoto

Professor and Chair

Hiroshima University Hospital

JAPAN
View details

Jin S. Im

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

John Thompson

Clinical Professor

University of Sydney

AUSTRALIA
View details

Samir M. Hanash

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Abel Gonzalez-Perez

Co-PI

IRB Barcelona

SPAIN
View details

Paul Corn

Chair

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Grant Fischer

Assistant Professor of Molecular Genetic Pathology (Tenure Track)

University of North Carolina at Chapel Hill

UNITED STATES
View details

Francisco Sanchez-Vega

Assistant Attending Computational Biologist

Memorial Sloan Kettering Cancer Center

UNITED STATES
View details

John V. Heymach

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Koichi Takahashi

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Chao Cheng

Associate Professor

Baylor College of Medicine

UNITED STATES
View details

J. Jack Lee

Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Reid T Powell

Assistant Professor

Texas A&M University

UNITED STATES
View details

Seong Gu Heo

Dana-Farber Cancer Institute

UNITED STATES
View details

Sangeeta Goswami

Associate Professor/ Joint Appointment

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Jennifer A. Wargo

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Elizabeth Burton

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Sreyashi Basu

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Natalie Vokes

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Aditya Mishra

University of Georgia

UNITED STATES
View details

Michael J. Overman

-

UNITED STATES
View details

Ryan Sun

Assistant Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Mara B. Antonoff

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Christine Spencer

Parker Institute for Cancer Immunotherapy

UNITED STATES
View details

Maxime Tarabichi

Group Leader

Université libre de Bruxelles

BELGIUM
View details

Cara Haymaker

Associate Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Gheath Alatrash

Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Dirk Schadendorf

University Hospital Essen

GERMANY
View details

Han Liang

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Ana Aparicio

Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

R. Tyler Hillman

Associate Professor

UC San Diego Health System

UNITED STATES
View details

Sumit Subudhi

Assistant Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Patrick Reville

Assistant Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Alexandre Reuben

Assistant Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

James Wilmott

Associate Professor

The University of Sydney Library

AUSTRALIA
View details

Simon Heeke

Assistant Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

john Davis

Associate Professor

MD Anderson Cancer Center

UNITED STATES
View details

Sean M Post

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Fatima Zahra Jelloul

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

yana najjar

University of Pittsburgh

UNITED STATES
View details

Edwin J. Ostrin

Associate Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Courtney D. DiNardo

University of Pennsylvania

UNITED STATES
View details

Alexander Lazar

Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

John Ward

Professor

MD Anderson Cancer Center

UNITED STATES
View details

Suyu Liu

Associate Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Nadim Ajami

Executive Director

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Ken Chen

Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Don L. Gibbons

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Humam Kadara

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Samantha Bersani

University of Verona

ITALY
View details

Richard A. Scolyer

Faculty Member

University of Sydney

AUSTRALIA
View details

Jia Wu

Associate Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Arif Harmanci

Assistant Professor

The University of Texas Health Science Center at Houston

UNITED STATES
View details

Nagireddy Putluri

Professor (Tenured)

Baylor College of Medicine

UNITED STATES
View details

Anke Katharina Bergmann

Director, Chair

University Hospital Würzburg

GERMANY
View details

Linghua Wang

Executive Director & Head

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Jared Burks

Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Christopher Ly

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Guillermo Garcia-Manero

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Naval G. Daver

Professor of Medicine

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Weiyi Peng

Director

University of Houston

UNITED STATES
View details